← Back to Search

Habit Reversal Training for Tourette Syndrome

N/A

Waitlist Available

Led By Joseph F McGuire, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 1 week after completion of hrt

Awards & highlights

Study Summary

This trial will explore how well youth with Tourette Syndrome respond to extinction learning (a type of therapy) and if this process can help treat TS.

Eligible Conditions

Tourette Syndrome
Habit Reversal Training
Tics

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 1 week after completion of hrt

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 1 week after completion of hrt

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week after completion of hrt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS)

Secondary outcome measures

Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Habit Reversal TrainingExperimental Treatment1 Intervention

Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 4 two-hour sessions in an intensive format.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Habit Reversal Training

2020

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,260 Previous Clinical Trials

14,820,760 Total Patients Enrolled

7 Trials studying Tourette Syndrome

165 Patients Enrolled for Tourette Syndrome

Joseph F McGuire, PhDPrincipal InvestigatorJohns Hopkins University

1 Previous Clinical Trials

10 Total Patients Enrolled

1 Trials studying Tourette Syndrome

10 Patients Enrolled for Tourette Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any patients being recruited for this trial at present?

"Affirmative, clinicaltrials.gov displays that this medical trial is actively seeking participants. The study was initially posted on February 28th 2019 and the details were most recently modified on October 6 2022. Fifty patients across a single site are necessary for enrollment in the experiment."

Answered by AI

How many participants have been included in this investigation?

"Affirmative. According to information on clinicaltrials.gov, the trial is currently recruiting participants, having initially been posted on February 28th 2019 and updated most recently in October 6th 2022. The study seeks 50 patients from a single site."

Answered by AI

Is the age range for participants of this trial below 70 years old?

"According to the study's inclusion parameters, individuals between 8 and 17 years old are eligible for enrollment."

Answered by AI

Who is eligible to take part in this investigation?

"The current medical trial is seeking 50 participants aged 8 to 17 years old with moderate or greater tic severity. Other eligibility criteria include having received fewer than 4 previous sessions of HRT, being medication-free for the last two months before enrollment or on a stable dose of psychiatric drugs during that period."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Extinction Learning in Youth With Tourette Syndrome

2019. "Extinction Learning in Youth With Tourette Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03765463.